» Articles » PMID: 22103978

The Seventh Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma is Prognostically Useful for Patients Treated with Intensity-modulated Radiotherapy from an Endemic Area in China

Overview
Journal Radiother Oncol
Specialties Oncology
Radiology
Date 2011 Nov 23
PMID 22103978
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the 7th edition of the International Union against Cancer/American Joint Committee on Cancer (UICC/AJCC) staging system for nasopharyngeal carcinoma (NPC) in patients treated with intensity-modulated radiotherapy.

Methods And Materials: We performed a retrospective data review from 512 patients with biopsy-proven, nonmetastatic NPC in our cancer center (South China) between January 2003 and December 2006.

Results: The local relapse-free survival rates (LRFS) and disease failure-free survival rates (DFS) in the 6th edition system T1 and T2a stages were not significantly different (P=0.629 and P=0.820), while the LRFS and DFS of T1 and T2 using the 7th edition system were significantly different (P=0.019 and P=0.009). The LRFS and DFS between T2 and T3 in the 7th edition systems were lack of significance (P=0.874 and P=0.589). The total difference in distant metastasis-free survival rate and DFS between N0 and N3 was slightly larger using the 7th edition system than the 6th edition. The nodal dimension of a cervical lymph node was not a significant prognostic factor.

Conclusions: We observed a better segregation of survival curves by using the 7th edition system. It seems reasonable to downstage T3 as T2 and reject nodal greatest dimension from the N-staging system in the future revised edition.

Citing Articles

Advances in Nasopharyngeal Carcinoma Staging: from the 7th to the 9th Edition of the TNM System and Future Outlook.

Wu B, Chen X, Cao C Curr Oncol Rep. 2025; .

PMID: 39998781 DOI: 10.1007/s11912-025-01651-9.


Intensity-modulated radiotherapy alone compared with intensity-modulated radiotherapy plus concurrent chemotherapy in intermediate-risk nasopharyngeal carcinoma : A prospective multicenter phase II trial.

Liao S, Zhang B, Su Y, Pan Y, Zhang J, Ye Z Strahlenther Onkol. 2024; 200(10):867-875.

PMID: 38324078 DOI: 10.1007/s00066-024-02201-1.


The prognostic nutritional index represents a novel inflammation-nutrition-based prognostic factor for nasopharyngeal carcinoma.

Jiang Y, Huang S, Pan X, Ma J, Zhu X Front Nutr. 2023; 10:1036572.

PMID: 36875852 PMC: 9977787. DOI: 10.3389/fnut.2023.1036572.


A dynamic nomogram combining tumor stage and magnetic resonance imaging features to predict the response to induction chemotherapy in locally advanced nasopharyngeal carcinoma.

Jiang Y, Liang Z, Chen K, Li Y, Yang J, Qu S Eur Radiol. 2022; 33(3):2171-2184.

PMID: 36355201 DOI: 10.1007/s00330-022-09201-8.


Platinum Plus Tegafur-Uracil versus Platinum Alone during Concurrent Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma: A Propensity-Score-Matching Analysis.

Lien C, Wang C, Yang C, Wang C, Hwang T, Shih Y Cancers (Basel). 2022; 14(18).

PMID: 36139674 PMC: 9496885. DOI: 10.3390/cancers14184511.